Jaguar Health, Inc. (JAGX) stock
JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.39−0.03 (-7.14%)
Close on Nov 16, 2026Market cap $2.02MP/E –Yield –
Jaguar Health cash
Cash and short-term investments held at the end of each period.
Jaguar Health's cash was $3.79M at Jun 30, 2026. For fiscal 2025 it was $968.00K, down 87.9% from the year before. Over ten years it grew -18.7% a year on average. The highest annual figure on record is $17.05M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $968.00K | -87.9% |
| FY2024 | Dec 31, 2024 | $8.00M | +23.7% |
| FY2023 | Dec 31, 2023 | $6.47M | +18.3% |
| FY2022 | Dec 31, 2022 | $5.47M | -67.9% |
| FY2021 | Dec 31, 2021 | $17.05M | +110.8% |
| FY2020 | Dec 31, 2020 | $8.09M | +108.3% |
| FY2019 | Dec 31, 2019 | $3.88M | +51.2% |
| FY2018 | Dec 31, 2018 | $2.57M | +238.0% |
| FY2017 | Dec 31, 2017 | $759.87K | -48.0% |
| FY2016 | Dec 31, 2016 | $1.46M | -81.0% |
| FY2015 | Dec 31, 2015 | $7.70M | +810.7% |
| FY2014 | Dec 31, 2014 | $845.19K | +356.0% |
| FY2013 | Dec 31, 2013 | $185.37K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.79M | +71.6% |
| Q1 FY2026 | Mar 31, 2026 | $7.28M | +27.9% |
| Q4 FY2025 | Dec 31, 2025 | $968.00K | -87.9% |
| Q3 FY2025 | Sep 30, 2025 | $3.53M | -73.4% |
| Q2 FY2025 | Jun 30, 2025 | $2.21M | -86.2% |
| Q1 FY2025 | Mar 31, 2025 | $5.69M | -51.2% |
| Q4 FY2024 | Dec 31, 2024 | $8.00M | +23.7% |
| Q3 FY2024 | Sep 30, 2024 | $13.27M | +311.3% |
| Q2 FY2024 | Jun 30, 2024 | $16.05M | +86.0% |
| Q1 FY2024 | Mar 31, 2024 | $11.67M | -18.8% |
| Q4 FY2023 | Dec 31, 2023 | $6.47M | +18.3% |
| Q3 FY2023 | Sep 30, 2023 | $3.23M | -69.5% |
| Q2 FY2023 | Jun 30, 2023 | $8.63M | -4.3% |
| Q1 FY2023 | Mar 31, 2023 | $14.37M | -17.7% |
| Q4 FY2022 | Dec 31, 2022 | $5.47M | -67.9% |
| Q3 FY2022 | Sep 30, 2022 | $10.56M | -14.7% |
| Q2 FY2022 | Jun 30, 2022 | $9.01M | -71.8% |
| Q1 FY2022 | Mar 31, 2022 | $17.46M | -45.9% |
| Q4 FY2021 | Dec 31, 2021 | $17.05M | +110.8% |
| Q3 FY2021 | Sep 30, 2021 | $12.38M | +817.3% |
| Q2 FY2021 | Jun 30, 2021 | $31.91M | +958.4% |
| Q1 FY2021 | Mar 31, 2021 | $32.25M | +2554.3% |
| Q4 FY2020 | Dec 31, 2020 | $8.09M | +108.3% |
| Q3 FY2020 | Sep 30, 2020 | $1.35M | -34.8% |
| Q2 FY2020 | Jun 30, 2020 | $3.02M | +87.6% |
| Q1 FY2020 | Mar 31, 2020 | $1.22M | -52.8% |
| Q4 FY2019 | Dec 31, 2019 | $3.88M | +51.2% |
| Q3 FY2019 | Sep 30, 2019 | $2.07M | +185.1% |
| Q2 FY2019 | Jun 30, 2019 | $1.61M | -33.4% |
| Q1 FY2019 | Mar 31, 2019 | $2.57M | +238.5% |
| Q4 FY2018 | Dec 31, 2018 | $2.57M | +1064.2% |
| Q3 FY2018 | Sep 30, 2018 | $726.13K | -73.7% |
| Q2 FY2018 | Jun 30, 2018 | $2.41M | +100.1% |
| Q4 FY2017 | Dec 31, 2017 | $759.87K | -48.0% |
| Q3 FY2017 | Sep 30, 2017 | $220.59K | -87.8% |
| Q2 FY2017 | Jun 30, 2017 | $2.76M | -28.8% |
| Q1 FY2017 | Mar 31, 2017 | $1.21M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.46M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.81M | – |
| Q2 FY2016 | Jun 30, 2016 | $3.88M | – |
See a number that looks wrong?